Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since May 14 · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in EAPH in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a EAPH trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for EAPH.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +100.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | -90.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −90.0% |
| 2024 | 0.0 | 0.0 | 0.0 | 0.0 | 400.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +400.0% |
| 2023 | 0.0 | -90.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −80.0% |
| 2022 | 0.0 | 0.0 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −50.0% |
| 2021 | 66.7 | 150.0 | -8.0 | -13.0 | -75.0 | -40.0 | -66.7 | 0.0 | 0.0 | 100.0 | -50.0 | 100.0 | −66.7% |
| 2020 | 80.0 | -38.9 | 81.8 | -50.0 | 0.0 | 0.0 | -20.0 | 0.0 | -37.5 | 20.0 | -16.7 | 20.0 | −40.0% |
| 2019 | -9.0 | -8.0 | 37.5 | -5.1 | -19.1 | -44.7 | 7.1 | -15.6 | -26.3 | -7.1 | 0.0 | -61.5 | −88.4% |
| 2018 | -11.7 | -28.3 | -13.2 | 4.8 | -13.3 | 2.0 | -34.6 | 74.0 | -31.6 | -1.7 | -5.1 | -22.5 | −71.3% |
| 2017 | 96.5 | -38.8 | -14.9 | -2.7 | -25.2 | -12.7 | 8.2 | 29.3 | -1.9 | -21.5 | 2.9 | 42.9 | +3.1% |
| 2016 | 5.4 | 38.5 | -7.4 | -20.0 | 0.0 | -5.0 | -28.9 | 5.6 | -22.8 | 536.4 | -15.7 | 146.6 | +686.5% |
| 2015 | 137.9 | -37.9 | -13.3 | -21.3 | -24.1 | 18.8 | -18.3 | -9.2 | -32.6 | 8.3 | -15.4 | -32.7 | −72.0% |
| 2014 | 1056.3 | 153.0 | 7.9 | -46.1 | -22.8 | -38.1 | 15.4 | 26.0 | -23.3 | 14.5 | -15.7 | -5.7 | +725.0% |
| 2013 | 111.5 | -45.7 | 100.0 | -21.4 | -40.9 | -27.7 | -70.2 | 457.1 | -37.2 | -38.8 | -16.7 | -36.0 | −73.8% |
| 2012 | -31.5 | 95.0 | -28.2 | -42.9 | 50.0 | -47.5 | 0.0 | 4.8 | -1.5 | 7.7 | -31.4 | 27.1 | −58.2% |
| 2011 | 0.0 | 61.9 | 8.8 | 2.7 | -57.9 | -6.2 | -6.7 | -81.4 | 96.2 | -56.9 | -31.8 | -2.7 | −93.0% |
| 2010 | 2900.0 | -48.9 | -27.5 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | -80.4 | 0.0 | 0.0 | 110.0 | +366.7% |
| 2009 | 0.0 | 16.7 | -42.9 | -25.1 | -97.2 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 12.5 | 0.0 | −97.5% |
| 2008 | 133.3 | -14.3 | -33.3 | 25.0 | 30.0 | -7.7 | 0.0 | -25.0 | 44.4 | -7.7 | -50.0 | 0.0 | −0.0% |
| 2007 | 71.4 | 2.8 | -29.7 | 0.0 | -23.1 | -5.0 | 42.1 | -59.3 | 0.0 | -9.1 | -30.0 | -14.3 | −71.4% |
No analyst coverage for this instrument.
Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.
No recent headlines.